Grant · Biotech
Athernal Bio receives nearly £700K Innovate UK grant
Athernal Bio received a grant of nearly £700,000 through Innovate UK’s Growth Catalyst–Investor Partnerships programme.
The grant supports operations and research and development at the preclinical biotechnology company.
Athernal is developing treatments for blood disease and cancer interception, including work on therapy-induced clonal haematopoiesis in cancer survivors.
Use of funds
Expand operations and research and development
Funding history
Grant · This round~£700K